Psyched Wellness to Participate in Upcoming Investor Conferences in April 2022
Psyched Wellness Ltd. is pleased to announce that Chief Executive Officer, Jeffrey Stevens, and Chief Commercial Officer, Matthew Singh, will be presenting at the following investor conferences, in April 2022.
Benzinga Psychedelics Capital Conference:
Date: April 19 at 3:00pm ET
Registration: https://www.benzinga.com/events/psychedelics/
Webcast: https://www.benzinga.com/events/psychedelics/livestream/
RHK NobleCon18:
Date: April 20 at 3:00pm ET
Registration: https://www.nobleconference.com/eighteen#register
Webcast: https://noble.mediasite.com/Mediasite/Play/eac8086a26464b159e3ae56f49d63afe1d
Mr. Singh commented: “Both Jeff and I are extremely excited to share the progress Psyched Wellness has made, in 2022. Beyond the standard introduction and insight into the positioning of our company, we will speak to the continued development of our proprietary extract, AME-1 (yielding the first legal Amanita Muscaria products in North America), the unique go-to-market benefits this extract affords us when it comes to retail upside, and our healthy financial position to execute our rollout plan, with revenue populating as early as Summer 2022. We truly believe Psyched Wellness has offerings no other company can rival.”
To schedule a one-on-one meeting with Psyched’s management team, please contact KCSA Strategic Communications at PsychedWellness@kcsa.com.